Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

株式のランク #2086
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
株価
$142.84
時価総額
$9.91B
変化(1日)
0.62%
変化(1年)
-56.30%
国
US
取引 Insulet Corp. (PODD)

カテゴリー

Healthcare
Insulet Corp.(PODD)の収益
Jun 2026 時点の収益 TTM: $3.05B
Insulet Corp. の最新の財務報告によると、現在の収益 (TTM) は $3.05B です。2023 年には $1.70B の収益があり、これは 2022 年の $1.31B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Insulet Corp. の収益履歴(2002 ~ 2026)
各年末の収益
年 収益 変化
2026 (TTM) $3.05B 47.40%
2024 $2.07B 22.07%
2023 $1.70B 30.02%
2022 $1.31B 18.79%
2021 $1.10B 21.49%
2020 $904.40M 22.51%
2019 $738.20M 30.93%
2018 $563.82M 21.57%
2017 $463.77M 26.37%
2016 $366.99M 39.07%
2015 $263.89M -8.60%
2014 $288.72M 16.85%
2013 $247.08M 16.90%
2012 $211.37M 38.83%
2011 $152.26M 57.02%
2010 $96.97M 46.85%
2009 $66.03M 83.12%
2008 $36.06M 169.66%
2007 $13.37M 265.06%
2006 $3.66M 7,226.00%
2005 $50.00K 0.00%
2004 0.00 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
同業他社の収益
企業 収益 収益の差 国
$46.59B 1,425.63%
US
$35.48B 1,062.08%
IE
$25.84B 746.14%
US
$21.00B 587.60%
US
- -
DE